PROCHLORPERAZINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Prochlorperazine, and what generic alternatives are available?
Prochlorperazine is a drug marketed by Alpharma Us Pharms, Baxter Hlthcare, Able, Cosette, Watson Labs, Morton Grove, Amneal, Avet Lifesciences, Caplin, Eugia Pharma, Gland Pharma Ltd, Hikma, Hospira, Marsam Pharms Llc, Mylan Labs Ltd, Nexus, Sagent, Smith And Nephew, Somerset Theraps Llc, Teva Parenteral, Viwit Pharm, Wyeth Ayerst, Ajanta Pharma Ltd, Bionpharma, Chartwell Rx, Duramed Pharms Barr, Glenmark Pharms Ltd, Ivax Sub Teva Pharms, Leading, Norvium Bioscience, Novitium Pharma, Teva Pharms, and Zydus Lifesciences. and is included in forty-six NDAs.
The generic ingredient in PROCHLORPERAZINE is prochlorperazine maleate. There are twenty-one drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the prochlorperazine maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Prochlorperazine
A generic version of PROCHLORPERAZINE was approved as prochlorperazine maleate by NOVITIUM PHARMA on June 13th, 2022.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROCHLORPERAZINE?
- What are the global sales for PROCHLORPERAZINE?
- What is Average Wholesale Price for PROCHLORPERAZINE?
Summary for PROCHLORPERAZINE
| US Patents: | 0 |
| Applicants: | 33 |
| NDAs: | 46 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 57 |
| Clinical Trials: | 50 |
| Patent Applications: | 4,143 |
| Drug Prices: | Drug price information for PROCHLORPERAZINE |
| Drug Sales Revenues: | Drug sales revenues for PROCHLORPERAZINE |
| DailyMed Link: | PROCHLORPERAZINE at DailyMed |
See drug prices for PROCHLORPERAZINE
Recent Clinical Trials for PROCHLORPERAZINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Assertio Holdings, Inc | Phase 2 |
| Washington University School of Medicine | Phase 2 |
| Dayton Children's Hospital | N/A |
Pharmacology for PROCHLORPERAZINE
| Drug Class | Phenothiazine |
Medical Subject Heading (MeSH) Categories for PROCHLORPERAZINE
Anatomical Therapeutic Chemical (ATC) Classes for PROCHLORPERAZINE
US Patents and Regulatory Information for PROCHLORPERAZINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Rx | PROCHLORPERAZINE MALEATE | prochlorperazine maleate | TABLET;ORAL | 040101-002 | Jul 19, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Alpharma Us Pharms | PROCHLORPERAZINE EDISYLATE | prochlorperazine edisylate | SYRUP;ORAL | 087154-001 | Sep 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glenmark Pharms Ltd | PROCHLORPERAZINE MALEATE | prochlorperazine maleate | TABLET;ORAL | 216595-002 | Mar 17, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Zydus Lifesciences | PROCHLORPERAZINE MALEATE | prochlorperazine maleate | TABLET;ORAL | 216495-001 | Aug 8, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Duramed Pharms Barr | PROCHLORPERAZINE MALEATE | prochlorperazine maleate | TABLET;ORAL | 040207-002 | May 1, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
